BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1682594)

  • 1. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine.
    Herroelen L; de Keyser J; Ebinger G
    Lancet; 1991 Nov; 338(8776):1174-5. PubMed ID: 1682594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype.
    Kaplanski G; Retornaz F; Durand J; Soubeyrand J
    J Neurol Neurosurg Psychiatry; 1995 Jun; 58(6):758-9. PubMed ID: 7608688
    [No Abstract]   [Full Text] [Related]  

  • 3. Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.
    Martínez-Sernández V; Figueiras A
    J Neurol; 2013 Aug; 260(8):1951-9. PubMed ID: 23086181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome following immunisation with synthetic hepatitis B vaccine.
    Tuohy PG
    N Z Med J; 1989 Mar; 102(863):114-5. PubMed ID: 2522608
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B vaccine and risk of multiple sclerosis.
    DeStefano F; Verstraeten T; Chen RT
    Expert Rev Vaccines; 2002 Dec; 1(4):461-6. PubMed ID: 12901584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccine associated with erythema nodosum and polyarthritis.
    Rogerson SJ; Nye FJ
    BMJ; 1990 Aug; 301(6747):345. PubMed ID: 2144199
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse reaction to the recombinant hepatitis B vaccine.
    Hudson TJ; Newkirk M; Gervais F; Shuster J
    J Allergy Clin Immunol; 1991 Nov; 88(5):821-2. PubMed ID: 1835467
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sclerotic plaques and hepatitis B vaccination in adults: the situation in 2004. Response].
    Confavreux C; Vukusic S; Arbizu T; Brochet B; Clanet M; Edan G; Kappos L; Suissa S
    Rev Neurol (Paris); 2005 Jul; 161(6-7):644-6; author reply 646-7. PubMed ID: 16145827
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board.
    Halsey NA; Duclos P; Van Damme P; Margolis H
    Pediatr Infect Dis J; 1999 Jan; 18(1):23-4. PubMed ID: 9951975
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.
    Mikaeloff Y; Caridade G; Assi S; Tardieu M; Suissa S;
    Brain; 2007 Apr; 130(Pt 4):1105-10. PubMed ID: 17276994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alleged link between hepatitis B vaccine and chronic fatigue syndrome.
    Can Dis Wkly Rep; 1991 Oct; 17(40):215-6. PubMed ID: 1835672
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute cerebellar ataxia after immunisation with recombinant hepatitis B vaccine.
    Deisenhammer F; Pohl P; Bösch S; Schmidauer C
    Acta Neurol Scand; 1994 Jun; 89(6):462-3. PubMed ID: 7976236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuralgic amyotrophy following recombinant DNA hepatitis B vaccination.
    Reutens DC; Dunne JW; Leather H
    Muscle Nerve; 1990 May; 13(5):461. PubMed ID: 2345565
    [No Abstract]   [Full Text] [Related]  

  • 15. [Central nervous system demyelinating disease following hepatitis B vaccination with GenHevac B. Review of ten years of spontaneous notifications (1989-1998)].
    Soubeyrand B; Boisnard F; Bruel M; Debois H; Delattre D; Gauthier A; Soum S; Thébault C
    Presse Med; 2000 Apr; 29(14):775-80. PubMed ID: 10816715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of intramuscular injection of hepatitis B vaccine in haemophiliacs.
    Evans DI; Shaw A
    BMJ; 1990 Jun; 300(6741):1694-5. PubMed ID: 2143948
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis.
    Mouchet J; Salvo F; Raschi E; Poluzzi E; Antonazzo IC; De Ponti F; Bégaud B
    Vaccine; 2018 Mar; 36(12):1548-1555. PubMed ID: 29454521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engerix-B hepatitis B vaccine (recombinant)/Smith, Kline & French.
    Swartz ML
    Gastroenterol Nurs; 1991; 13(3):158-61. PubMed ID: 1825929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic adverse effects of hepatitis B vaccines are rare.
    Prescrire Int; 2004 Dec; 13(74):218-23. PubMed ID: 15612143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The first episode of central nervous system demyelinization and hepatitis B virus vaccination].
    Touzé E; Gout O; Verdier-Taillefer MH; Lyon-Caen O; Alpérovitch A
    Rev Neurol (Paris); 2000 Mar; 156(3):242-6. PubMed ID: 10740095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.